Invion Limited (ASX:IVX)
Australia · Delayed Price · Currency is AUD 0.0990
+0.0030 (3.13%)
Aug 1, 2025, 3:03 PM AEST
Invion Market Cap
Invion has a market cap or net worth of 8.46 million as of August 1, 2025. Its market cap has decreased by -67.99% in one year.
Market Cap
8.46M
Enterprise Value
7.72M
Revenue
1.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since February 15, 2010, Invion's market cap has decreased from 23.91M to 8.46M, a decrease of -64.63%. That is a compound annual growth rate of -6.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 8.46M | -56.40% |
| Dec 31, 2024 | 19.39M | -39.60% |
| Dec 29, 2023 | 32.11M | -44.43% |
| Dec 30, 2022 | 57.78M | -57.12% |
| Dec 31, 2021 | 134.75M | 143.32% |
| Dec 31, 2020 | 55.38M | -22.56% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 127.86B |
| Pro Medicus | 32.80B |
| Cochlear | 20.43B |
| Sonic Healthcare | 13.51B |
| Ramsay Health Care | 8.74B |
| Telix Pharmaceuticals | 6.82B |
| Ansell | 4.35B |
| Mesoblast | 3.01B |